HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott E Nelson Selected Research

Breast Neoplasms (Breast Cancer)

1/2022Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott E Nelson Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 03/2006
3Type 2 Diabetes Mellitus (MODY)
01/2011 - 06/2005
2Inflammation (Inflammations)
01/2021 - 06/2005
2Hypoglycemia (Reactive Hypoglycemia)
01/2011 - 05/2006
1Carcinoma (Carcinomatosis)
01/2022
1Leukemia
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Carcinogenesis
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Epstein-Barr Virus Infections
01/2021
1Infections
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1Lymphoma (Lymphomas)
01/2020
1Diabetes Complications
10/2011
1Diabetes Mellitus
01/2011
1Weight Gain
05/2006
1Atherosclerosis
06/2005

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2006
4Insulin (Novolin)FDA Link
01/2011 - 06/2005
1RON proteinIBA
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1SyndecansIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Syndecan-2IBA
01/2022
1lysophosphatidic acidIBA
01/2021
1Phorbol EstersIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020
1Blood Glucose (Blood Sugar)IBA
10/2011
1Insulin Detemir (Levemir)FDA Link
01/2011
1Glucose (Dextrose)FDA LinkGeneric
05/2006
1Amino AcidsFDA Link
03/2006

Therapy/Procedure

3Therapeutics
01/2022 - 06/2005
2Glycemic Control
01/2011 - 05/2006